REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Medigen Vaccine Biologics Corporation (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing | Research and Development in the Physical, Engineering, and Life Sciences
Full name: Medigen Vaccine Biologics Corporation Profile Updated: July 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Medigen Vaccine Biologics Corporation is engaged in vaccine development. The Company was incorporated in 2012 and is headquartered in New Taipei City, Taipei.

Headquarters
No.68, Shengyi 3rd Rd., Zhubei City, hsinchu, Taiwan
Hsinchu County; Hsinchu County;

Contact Details: Purchase the Medigen Vaccine Biologics Corporation report to view the information.

Website: http://www.medigenvac.com

Basic Information
Total Employees:
Purchase the Medigen Vaccine Biologics Corporation report to view the information.
Outstanding Shares:
Purchase the Medigen Vaccine Biologics Corporation report to view the information.
Financial Auditors:
Purchase the Medigen Vaccine Biologics Corporation report to view the information.
Incorporation Date:
October 22, 2012
Key Executives
Purchase this report to view the information.
Chairman of the Board of Directors
Purchase this report to view the information.
President
Purchase this report to view the information.
Spokesperson
Ownership Details
Purchase this report to view the information.
19.31%
Purchase this report to view the information.
3.33%
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Mvc Biopharma Ltd. (United Kingdom)
100%
高端資本股份有限公司
100%
Company Performance
Financial values in the chart are available after Medigen Vaccine Biologics Corporation report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
80.91%▲
EBITDA
90.51%▲
Net Profit (Loss) for the Period
88.61%▲
Total assets
-35.27%▼
Total equity
-14.48%▼
Return on Equity (ROE)
10.13%▲
Debt to Equity Ratio
6.95%▲
Quick Ratio
7.61%▲
Cash Ratio
4.65%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo